The history of copyright's flagship drug presents a complex case for investors in the medicinal sector. While initially a tremendous success, generating huge profits, the exclusivity lapse and the subsequent flood of https://knockoff684387.vblogetin.com/47877857/sildenafil-and-big-pharma-a-risky-investment